D.R. Horton Surpasses Sales Expectations With 9% Surge, Outlines Optimistic 2024 Outlook

Builder D.R. Horton, Inc DHI reported fourth-quarter FY23 sales growth of 9% year-over-year to $10.50 billion, beating the consensus of $10.01 billion.

Net sales orders increased 39% Y/Y to 18,939 homes and 34% Y/Y in value to $7.3 billion.

Home sales revenues of $8.8 billion (-6.4% Y/Y) on 22,928 (-1.2% Y/Y) homes closed.

EPS was $4.45 (-4.7% Y/Y), beating the consensus of $3.93.

The company's sales order backlog of homes under contract as of Sept. 30, 2023, decreased 23% to 15,197 homes and fell 26% in value to $5.9 billion, compared to the prior year period.

DHI had 42,000 homes in inventory, of which 27,000 were unsold as of Sept. 30, 2023.

Return on equity or ROE was 22.7% for FY23, and homebuilding return on inventory (ROI) was 29.7%.

DHI's net cash provided by operations for fiscal 2023 totaled $4.3 billion, compared to $561.8 million in 2022. Its consolidated cash balance on Sept. 30, 2023, was $3.9 billion, and available capacity on its credit facilities was $3.6 billion, for a total liquidity of $7.5 billion. 

The debt-to-total capital ratio on Sept. 30, 2023 was 18.3%. 

Buyback: DHI repurchased 3.5 million shares of common stock for $423.1 million during the quarter. The company's remaining stock repurchase authorization on Sept. 30, 2023, was $234 million.

Dividend Increased: DHI declared a quarterly cash dividend of $0.30 per common share, an increase of 20% compared to its most recent dividend. The dividend is payable on Nov. 28, 2023, to stockholders of record on November 21, 2023.

FY24 Outlook: DHI sees revenue of $36 billion-$37 billion, versus the consensus of $36.20 billion.

It expects Homes closed to be between 86,000 homes to 89,000 homes. DHI expects cash provided by operations greater than $3 billion and repurchases of ~$1.5 billion.

Price Action: DHI shares are trading higher by 3.7% at $122.10 at the last check Tuesday.

Now Read: Lucid To Adopt Tesla Superchargers: Elon Musk Weighs In, Says, 'A Bitter Pill To Swallow'

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...